Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

19.310
+0.2001.05%
Volume:3.29M
Turnover:63.92M
Market Cap:31.40B
PE:11.07
High:19.980
Open:19.360
Low:19.200
Close:19.110
52wk High:20.400
52wk Low:15.014
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:1.97
T/O Rate:1.50%
Dividend:0.90
Dividend Rate:4.67%
EPS(LYR):1.744
ROE:7.97%
ROA:2.85%
PB:0.74
PE(LYR):11.07
PS:0.36

Loading ...

Eight Government Bodies Issue Plan to Boost Traditional Chinese Medicine Industry Development

Stock News
·
Yesterday

JPMorgan Boosts Stake in Baiyunshan by 360,600 Shares at HK$18.85 Each

Stock News
·
Feb 04

Guangzhou Baiyunshan (00874) Publishes January 2026 Monthly Return on Movements in Securities

Bulletin Express
·
Feb 03

Baiyunshan Pharmaceutical's Unit Gets License to Produce Xuhanting Granules

MT Newswires Live
·
Feb 03

Baiyunshan (00874): Subsidiary's Pharmaceutical Production License Amended

Stock News
·
Feb 02

LSV Asset Management Boosts Stake in BaiYunShan PH (00874) by 30,000 Shares at HK$18.11 Per Share

Stock News
·
Jan 07

Baiyunshan (00874): Subsidiary Guangyao Phase II Fund Signs Partnership Agreement I with Guangyao Capital and Guangkai Fund to Establish Guangyao Guangkai Fund

Stock News
·
Dec 29, 2025

Guangzhou Baiyunshan Pharmaceutical - Unit to Contribute RMB99.50 Mln to Participate in Establishment of Gp Liwan Fund

THOMSON REUTERS
·
Dec 22, 2025

Hong Kong Releases TCM Development Blueprint with Eight Key Goals to Drive High-Quality Growth (Including Related Stocks)

Stock News
·
Dec 19, 2025

Guangzhou Baiyunshan Pharmaceutical - Unit to Acquire 100% Stake in Zhejiang Pharmaceutical Industry for RMB500.50 Mln

THOMSON REUTERS
·
Dec 17, 2025

Baiyunshan Pharma Unit Cancels Drug Production License

MT Newswires Live
·
Dec 16, 2025

JPMorgan Reduces Stake in BAIYUNSHAN PH (00874) by 112,000 Shares at HK$18.581 per Share

Stock News
·
Dec 15, 2025

Guangzhou Baiyun Mountain Scenic Area Administration Fined 850,000 Yuan for 27 Illegal Constructions

Deep News
·
Dec 09, 2025

JPMorgan Increases Stake in BAIYUNSHAN PH (00874) by 220,000 Shares at HK$18.92 per Share

Stock News
·
Dec 05, 2025

Guangzhou Baiyunshan (00874) Announces Proposal for GP Corp. to Securitize Accounts Receivable Up to RMB3 Billion

Bulletin Express
·
Dec 01, 2025

BRIEF-Guangzhou Baiyunshan Pharmaceutical Says GP Corp. Would Sell Accounts Receivable To Administrator

Reuters
·
Dec 01, 2025

BAIYUNSHAN PH (00874): Guangzhou Pharmaceutical Plans to Launch Accounts Receivable Securitization Business

Stock News
·
Dec 01, 2025

Guangzhou Baiyunshan Pharmaceutical - Gp Corp. Would Sell Accounts Receivable to Administrator

THOMSON REUTERS
·
Dec 01, 2025

Guangzhou Baiyunshan Pharmaceutical - Would Establish Special Scheme for Issuance of Asset-Backed Securities in Aggregate of No More Than RMB3 Bln

THOMSON REUTERS
·
Dec 01, 2025

Guangzhou Baiyunshan (00874.HK, 600332.SSE) Announces No Change in November 2025 Share Capital

Bulletin Express
·
Dec 01, 2025